144 related articles for article (PubMed ID: 32019590)
1. Introduction to the special issue.
Finlay A; Binswanger I; Timko C
Addict Sci Clin Pract; 2020 Feb; 15(1):5. PubMed ID: 32019590
[TBL] [Abstract][Full Text] [Related]
2. A conceptual model for understanding post-release opioid-related overdose risk.
Joudrey PJ; Khan MR; Wang EA; Scheidell JD; Edelman EJ; McInnes DK; Fox AD
Addict Sci Clin Pract; 2019 Apr; 14(1):17. PubMed ID: 30982468
[TBL] [Abstract][Full Text] [Related]
3. Understanding the importance of organizational and system variables on addiction treatment services within criminal justice settings.
McCarty D; Chandler RK
Drug Alcohol Depend; 2009 Aug; 103 Suppl 1():S91-3. PubMed ID: 19356862
[TBL] [Abstract][Full Text] [Related]
4. A Review of Opportunities to Improve the Health of People Involved in the Criminal Justice System in the United States.
Freudenberg N; Heller D
Annu Rev Public Health; 2016; 37():313-33. PubMed ID: 26789388
[TBL] [Abstract][Full Text] [Related]
5. Standards for opioid treatment in the criminal justice system: implications for nurses.
Chavez RS
J Addict Nurs; 2012 Feb; 23(1):40-6. PubMed ID: 22468659
[TBL] [Abstract][Full Text] [Related]
6. PROTOCOL: Opioid-specific medication-assisted therapy and its impact on criminal justice and overdose outcomes.
Strange CC; Manchak SM; Hyatt JM; Haberman C; Desai A
Campbell Syst Rev; 2021 Mar; 17(1):e1138. PubMed ID: 37050968
[TBL] [Abstract][Full Text] [Related]
7. Breaking the addictive cycle of the system: improving US criminal justice practices to address substance use disorders.
Kopak AM
Int J Prison Health; 2015; 11(1):4-16. PubMed ID: 25751703
[TBL] [Abstract][Full Text] [Related]
8. Organizational-level correlates of the provision of detoxification services and medication-based treatments for substance abuse in correctional institutions.
Oser CB; Knudsen HK; Staton-Tindall M; Taxman F; Leukefeld C
Drug Alcohol Depend; 2009 Aug; 103 Suppl 1(Suppl 1):S73-81. PubMed ID: 19108957
[TBL] [Abstract][Full Text] [Related]
9. Injecting Opioid Use Disorder Treatment in Jails and Prisons: The Potential of Extended-release Buprenorphine in the Carceral Setting.
Berk J; Del Pozo B; Rich JD; Lee JD
J Addict Med; 2022 Jul-Aug 01; 16(4):396-398. PubMed ID: 34954747
[TBL] [Abstract][Full Text] [Related]
10. Racial Disparities in Payment Source of Opioid Use Disorder Treatment among Non-Incarcerated Justice-Involved Adults in the United States.
Sanmartin MX; McKenna RM; Ali MM; Krebs JD
J Ment Health Policy Econ; 2020 Mar; 23(1):19-25. PubMed ID: 32458814
[TBL] [Abstract][Full Text] [Related]
11. Evidence-based treatment and supervision practices for co-occurring mental and substance use disorders in the criminal justice system.
Peters RH; Young MS; Rojas EC; Gorey CM
Am J Drug Alcohol Abuse; 2017 Jul; 43(4):475-488. PubMed ID: 28375656
[TBL] [Abstract][Full Text] [Related]
12. Understanding interactions of formerly incarcerated HIV-positive men and transgender women with substance use treatment, medical, and criminal justice systems.
Harawa NT; Amani B; Rohde Bowers J; Sayles JN; Cunningham W
Int J Drug Policy; 2017 Oct; 48():63-71. PubMed ID: 28804052
[TBL] [Abstract][Full Text] [Related]
13. Treating drug abuse and addiction in the criminal justice system: improving public health and safety.
Chandler RK; Fletcher BW; Volkow ND
JAMA; 2009 Jan; 301(2):183-90. PubMed ID: 19141766
[TBL] [Abstract][Full Text] [Related]
14. Utilization of substance use treatment among criminal justice-involved individuals in the United States.
Rowell-Cunsolo TL; Bellerose M
J Subst Abuse Treat; 2021 Jun; 125():108423. PubMed ID: 33906780
[TBL] [Abstract][Full Text] [Related]
15. Recovery-oriented care for drug-abusing offenders.
Heaps MM; Lurigio AJ; Rodriguez P; Lyons T; Brookes L
Addict Sci Clin Pract; 2009 Apr; 5(1):31-6. PubMed ID: 19369917
[TBL] [Abstract][Full Text] [Related]
16. Associations of criminal justice and substance use treatment involvement with HIV/HCV testing and the HIV treatment cascade among people who use drugs in Oakland, California.
Lambdin BH; Kral AH; Comfort M; Lopez AM; Lorvick J
Addict Sci Clin Pract; 2017 Jun; 12(1):13. PubMed ID: 28610602
[TBL] [Abstract][Full Text] [Related]
17. Opioid Agonist Treatment Recipients within Criminal Justice-Involved Populations.
Guastaferro WP; Koetzle D; Lutgen-Nieves L; Teasdale B
Subst Use Misuse; 2022; 57(5):698-707. PubMed ID: 35172673
[No Abstract] [Full Text] [Related]
18. Substance abuse prevention and treatment within the criminal justice system: an overview of the issues.
Campbell-Heider N; Baird C
J Addict Nurs; 2012 Feb; 23(1):7-13. PubMed ID: 22468655
[TBL] [Abstract][Full Text] [Related]
19. Jail-to-community treatment continuum for adults with co-occurring substance use and mental disorders: study protocol for a pilot randomized controlled trial.
Van Dorn RA; Desmarais SL; Rade CB; Burris EN; Cuddeback GS; Johnson KL; Tueller SJ; Comfort ML; Mueser KT
Trials; 2017 Aug; 18(1):365. PubMed ID: 28778175
[TBL] [Abstract][Full Text] [Related]
20. Improving Access to Substance Abuse Treatment and Reducing Incarceration and Recidivism.
Brolin M; Dennehy K; Booxbaum A; Horgan C
Issue Brief (Mass Health Policy Forum); 2015 Nov; (44):1-46. PubMed ID: 27911072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
